Pauline Frank

There is a lot of noise about patient centricity and engagement in the industry, but what do people who actually run clinical trials think about it? Assumptions and misperceptions are quite consistent among those who have not been actively involved in engaging with patients around clinical trial design and burden.

Join this session to discuss:

• What do patients actually think about, when considering participating in a clinical trial?
• Is the path to patient centricity in clinical trials really possible, even if not from "big Pharma"? What in reality does it require from clinical trial teams?
• What does this all mean for future clinical trial supply management?